Scarica l'app Stockscreener
4.83
0.21%
0.010
Dopo l'orario di chiusura:
5.40
0.57
+11.80%
Precedente Chiudi:
$4.82
Aprire:
$4.86
Volume 24 ore:
1.53M
Relative Volume:
1.02
Capitalizzazione di mercato:
$612.99M
Reddito:
$433.14M
Utile/perdita netta:
$4.95M
Rapporto P/E:
135.29
EPS:
0.0357
Flusso di cassa netto:
$6.55M
1 W Prestazione:
+3.65%
1M Prestazione:
-20.82%
6M Prestazione:
+57.33%
1 anno Prestazione:
+42.06%
Intervallo 1D:
$4.75
$5.00
Intervallo di 1 settimana:
$4.605
$5.00
Portata 52W:
$2.6101
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Nome
Organogenesis Holdings Inc
Settore
Telefono
781-575-0775
Indirizzo
85 DAN ROAD, CANTON, MA
Confronta ORGO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.83 | 611.72M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
120.98 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.61 | 45.27B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.13 | 34.18B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.30 | 21.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Lake Street | Buy |
| 2024-02-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Iniziato | SVB Leerink | Outperform |
| 2019-08-26 | Ripresa | Credit Suisse | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
| 2019-04-17 | Iniziato | Oppenheimer | Outperform |
| 2019-04-11 | Iniziato | SunTrust | Buy |
Mostra tutto
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - The Manila Times
Organogenesis to submit rolling BLA for knee osteoarthritis treatment By Investing.com - Investing.com Australia
Organogenesis stock soars after FDA meeting clears path for ReNu BLA - Investing.com
Organogenesis Holdings Inc. Initiates Rolling BLA Submission for ReNu Targeting Knee Osteoarthritis Expected by End of 2025 - Quiver Quantitative
Organogenesis announces successful FDA meeting and plan to file BLA for ReNu® - marketscreener.com
Organogenesis Holdings Inc. Announces Successful FDA Meeting and Plan to File BLA for Knee Osteoarthritis Pain - marketscreener.com
December 2025's Top Penny Stocks With Promising Potential - simplywall.st
Organogenesis: High-Tech Skin Substitute Company On Sale (NASDAQ:ORGO) - Seeking Alpha
Investors in cash trouble should check out Organogenesis Holdings Inc (ORGO) - setenews.com
Why analysts remain bullish on Organogenesis Holdings Inc. stockEarnings Beat & Technical Entry and Exit Alerts - Newser
Is Organogenesis Holdings Inc. stock attractive for income investorsMarket Movers & Technical Buy Zone Confirmation - Newser
Organogenesis Holdings Inc. (NASDAQ:ORGO) Surges 29% Yet Its Low P/S Is No Reason For Excitement - 富途牛牛
What makes Organogenesis Holdings Inc. (2PQ) stock appealing to growth investorsPortfolio Update Summary & Reliable Intraday Trade Plans - Newser
Take off with Organogenesis Holdings Inc (ORGO): Get ready for trading - Setenews
How Organogenesis Holdings Inc. (2PQ) stock reacts to monetary easingWeekly Profit Report & Weekly Breakout Opportunity Watchlist - Newser
Published on: 2025-12-02 06:45:13 - Newser
Why Organogenesis Holdings Inc. stock attracts high net worth investors2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
How dovish Fed policy supports Organogenesis Holdings Inc. (2PQ) stockTrend Reversal & Verified Trade Idea Suggestions - Newser
Organogenesis Holdings (ORGO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Have Organogenesis Holdings Insiders Been Selling Stock? - simplywall.st
Organogenesis Holdings Insider Sold Shares Worth $1,592,120, According to a Recent SEC Filing - marketscreener.com
Glenn Nussdorf Sells 100,000 Shares of Organogenesis (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis director Nussdorf sells $1.59 million in shares By Investing.com - Investing.com Australia
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Shares Bounce 27% But Its Business Still Trails The Industry - simplywall.st
Glenn Nussdorf Sells 187,957 Shares of Organogenesis (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis director Nussdorf sells $1.59 million in shares - Investing.com
Dir Nussdorf Sells 300,000 ($1.6M) Of Organogenesis Holdings Inc [ORGO] - TradingView
An analyst sees good growth prospects for Organogenesis Holdings Inc (ORGO) - Setenews
Dir Nussdorf Files To Sell 200,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Organogenesis (NASDAQ:ORGO) Trading Down 3.3%Here's What Happened - MarketBeat
Dir Nussdorf Files To Sell 100,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Organogenesis (NASDAQ:ORGO) Price Target Raised to $9.00 - Defense World
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders solid 26% CAGR over 3 years - Yahoo Finance
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders splendid 26% CAGR over 3 years - simplywall.st
Organogenesis (NASDAQ:ORGO) Trading Up 6.2% After Analyst Upgrade - Defense World
Organogenesis Holdings Inc.Class A (NQ: ORGO - Markets Financial Content
Is Organogenesis Holdings Inc. (2PQ) stock supported by strong fundamentalsPortfolio Profit Report & Weekly Stock Performance Updates - newser.com
Organogenesis stock price target raised to $9 by BTIG on reimbursement changes - Investing.com South Africa
Global Wound Healing Devices Market Poised for Robust Growth at a CAGR of ~5% by 2032, Driven by Rising Chronic Wound Burden | DelveInsight - GlobeNewswire Inc.
Can Organogenesis Holdings Inc. stock surprise with earnings upsideJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock attract more institutional investorsQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock supported by free cash flowWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock maintain dividend yieldPortfolio Risk Summary & Low Risk Entry Point Tips - newser.com
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):